Zeo ScientifiX, Inc. 8-K

What Happened
Zeo ScientifiX, Inc. (NASDAQ: ZEOX) announced on June 9, 2026 (Item 8.01 filing) that it expanded its Medical Advisory Board by adding nine physicians and scientific innovators. The new members cover key disciplines in regenerative and longevity medicine. The company included the press release announcing the additions as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: June 9, 2026 (Form 8-K, Item 8.01 Other Events).
• Number of additions: nine new medical and scientific advisors.
• Focus areas: regenerative medicine and longevity medicine (cross-disciplinary clinical and scientific expertise).
• Press release included as Exhibit 99.1 to the 8-K.

Why It Matters
An expanded Medical Advisory Board can provide Zeo ScientifiX with broader clinical and scientific guidance, potentially strengthening its research, development strategy, and credibility with partners or investors. The 8-K is a factual disclosure of the advisory appointments; it does not include financial results or changes in management. Investors should view this as a non-financial corporate development that may support the company’s scientific roadmap.